Clinical trials
Phase 2 Fallopian Tube Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Corcept Therapeutics | 2 |
| Belgian Gynaecological Oncology Group | 1 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| North Eastern German Society of Gynaecological Oncology | 1 |
| Seagen Inc. | 1 |
| TORL Biotherapeutics, LLC | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 12 |
| Ovarian Neoplasms | 10 |
| Neoplasms | 4 |
| Peritoneal Neoplasms | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Endometrial Neoplasms | 2 |
| Fallopian Tube Diseases | 2 |
| Genital Neoplasms, Female | 2 |
| Ovarian Diseases | 2 |
| Adenocarcinoma, Clear Cell | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.